As Merit Med Sys INC (MMSI) Stock Price Rose, Holder Aristotle Capital Boston LLC Lowered Holding

October 13, 2018 - By Linda Rogers

Merit Medical Systems, Inc. (NASDAQ:MMSI) LogoInvestors sentiment decreased to 1.13 in 2018 Q2. Its down 0.40, from 1.53 in 2018Q1. It turned negative, as 25 investors sold MMSI shares while 69 reduced holdings. 33 funds opened positions while 73 raised stakes. 45.77 million shares or 3.47% more from 44.23 million shares in 2018Q1 were reported. Frontier Cap Mgmt Llc has 0.33% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI). Deutsche Retail Bank Ag reported 117,804 shares or 0% of all its holdings. Parkside Bancshares And, a Missouri-based fund reported 39 shares. 1492 Capital Ltd owns 27,171 shares or 0.99% of their US portfolio. Sumitomo Mitsui Asset Management Limited has 34,990 shares. Riverhead Mgmt Ltd Com reported 0.01% stake. Citigroup Incorporated owns 20,132 shares for 0% of their portfolio. Raymond James Assoc stated it has 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Blair William & Il stated it has 15,399 shares or 0.01% of all its holdings. Arrowmark Colorado Holdings Ltd Liability Com invested in 258,655 shares or 0.12% of the stock. Fiera Cap Corporation has 167,384 shares. Victory Cap Management holds 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 3,069 shares. Etrade Cap Mngmt Lc stated it has 0.04% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Public Sector Pension Inv Board holds 32,513 shares. Brown Advisory Inc invested 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI).

Since June 5, 2018, it had 0 insider purchases, and 4 insider sales for $2.68 million activity. Shares for $990,153 were sold by Wright Joseph on Wednesday, June 13. Lampropoulos Justin J. also sold $718,326 worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) on Tuesday, June 5. $364,642 worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) was sold by Miller Franklin J.

Aristotle Capital Boston Llc decreased its stake in Merit Med Sys Inc (MMSI) by 48.01% based on its latest 2018Q2 regulatory filing with the SEC. Aristotle Capital Boston Llc sold 434,214 shares as the company’s stock rose 23.79% with the market. The institutional investor held 470,123 shares of the health care company at the end of 2018Q2, valued at $24.07 million, down from 904,337 at the end of the previous reported quarter. Aristotle Capital Boston Llc who had been investing in Merit Med Sys Inc for a number of months, seems to be less bullish one the $3.39B market cap company. The stock increased 1.66% or $1.01 during the last trading session, reaching $62.01. About 448,505 shares traded or 3.30% up from the average. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 47.00% since October 13, 2017 and is uptrending. It has outperformed by 31.38% the S&P500.

Analysts await Merit Medical Systems, Inc. (NASDAQ:MMSI) to report earnings on October, 24. They expect $0.42 EPS, up 31.25 % or $0.10 from last year’s $0.32 per share. MMSI’s profit will be $22.99 million for 36.91 P/E if the $0.42 EPS becomes a reality. After $0.43 actual EPS reported by Merit Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -2.33 % negative EPS growth.

More news for Merit Medical Systems, Inc. (NASDAQ:MMSI) were recently published by: Globenewswire.com, which released: “Merit Medical Signs Agreement to Acquire Cianna Medical, Inc.” on October 01, 2018. Globenewswire.com‘s article titled: “Merit Medical to Present at Three Upcoming Conferences” and published on September 19, 2018 is yet another important article.

Merit Medical Systems, Inc. (NASDAQ:MMSI) Ratings Coverage

Among 4 analysts covering Merit Medical Systems (NASDAQ:MMSI), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical Systems had 8 analyst reports since April 19, 2018 according to SRatingsIntel. The company was maintained on Tuesday, July 24 by Canaccord Genuity. The rating was maintained by Raymond James on Thursday, April 26 with “Outperform”. Needham initiated Merit Medical Systems, Inc. (NASDAQ:MMSI) rating on Thursday, April 19. Needham has “Buy” rating and $5300 target. On Tuesday, July 24 the stock rating was maintained by Raymond James with “Outperform”. The firm earned “Buy” rating on Thursday, April 26 by Canaccord Genuity. The firm earned “Buy” rating on Thursday, April 26 by Needham. The company was maintained on Monday, June 4 by Wells Fargo. Needham maintained Merit Medical Systems, Inc. (NASDAQ:MMSI) rating on Thursday, May 31. Needham has “Buy” rating and $5400 target.

Merit Medical Systems, Inc. (NASDAQ:MMSI) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>